Efficacy of Lumiracoxib in Osteoarthritis: a Review of Nine Studies

Author： Berenbaum F   Grifka J   Brown JP   Zacher J   Moore A   Krammer G   Dutta D   Sloan VS  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.33, Iss.1, 2005-01, pp. : 21-41

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lumiracoxib: new COX-2 inhibitor effective in osteoarthritis

By  

Inpharma, Vol. 1, Iss. 1403, 2003-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Lumiracoxib

By Katherine A. Lyseng-Williamson   Monique P. Curran  

Drugs, Vol. 64, Iss. 19, 2004-01 ,pp. : 2237-2246

Adis International

Access to resources Recommend Favorite

Naproxcinod shows efficacy in knee osteoarthritis

By  

Inpharma, Vol. 1, Iss. 1615, 2007-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Lumiracoxib [Prexige] appears to have a significantly less impact on BP than ibuprofen in patients with osteoarthritis who also have controlled hypertension

By  

Reactions Weekly, Vol. 1, Iss. 1157, 2007-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Valdecoxib vs naproxen: similar efficacy in osteoarthritis

By  

Inpharma, Vol. 1, Iss. 1344, 2002-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite